We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Wound Care System Treats High Risk Surgical Incisions

By HospiMedica International staff writers
Posted on 09 Oct 2013
An ultraportable negative pressure wound therapy (NPWT) system promotes the healing of a surgical closed incisions (CIs), including those in anatomically challenging locations.

The ciSNaP system with controlled tension relief helps reduce surgical CI complications such as infection and dehiscence by promoting active healing, using the efficacy of NPWT. More...
The system is comprised of a sterile cartridge that provides negative pressure to increase blood flow to the incision site, improving wound healing. The small, silent, single use design delivers therapy without batteries or electricity, using a proprietary spring mechanism that generates consistent, even levels of pressure. A visual indicator displays when the cartridge is full or discharged.

The system includes a controlled tension relief layer with silicone wings that help to approximate wound edges, thus reducing potential risk of dehiscence and minimizing tension on staples and sutures. A proprietary hydrocolloid dressing and antimicrobial gauze offer a protective barrier to minimize potential for infection, eliminating the need for dressing changes. Customizable dressing lengths are available to fit a wide range of incisions, all with a secure seal that allows patient to shower. The ciSNaP system is a product of Spiracur (Sunnyvale, CA, USA).

“Our investment in research and development will continue to produce innovative wound healing solutions such as the new ciSNaP System,” said Gary Restani, president and CEO of Spiracur. “This device combines the proven clinical effectiveness of negative pressure therapy with an advanced controlled tension relief layer to help minimize infection and improve wound healing, offering an ideal solution for patients undergoing complex surgeries.”

“I use the new ciSNaP on my higher-risk surgeries because it provides extra protection and stability to the incision,” said Christopher Bellicini, DO, of Excela Health Orthopedics and Sports Medicine (Greensburg, PA, USA). “In my experience, the new device produces excellent results by completely eliminating the need for daily non-sterile dressing changes during the patient’s hospital stay and instead, promoting successful healing of these high-risk wounds. As a result, the threat of infection and the possibility of dehiscence are minimized considerably.”

NPWT involves application of controlled subatmospheric pressure to the local wound environment. Due to its capacity to promote wound healing, NPWT has become standard practice in the field of advanced wound care. Although the body of evidence showing the beneficial effects of NPWT for healing wounds is accumulating, the precise wound healing mechanisms remain unclear.

Related Links:

Spiracur



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.